Dr Helen Parrington

​Helen is a postdoctoral research fellow in the Chappell Group working on the Rapid Response Vaccine Pipeline. Helen completed her PhD at Vanderbilt University in Nashville, Tennessee in 2023. For her thesis work, Helen developed the first human monoclonal antibodies against Sosuga virus — a recently discovered, bat-borne paramyxovirus. For her postdoc, Helen will assist with the development of subunit vaccines against various viral targets.

Key Publications

​Parrington HM, Nurgun K, Armstrong E, Handal L, Diaz S, Reidy J, Dong J, Stewart-Jones GBE, Shrivastava-Ranjan P, Jain S, Albariño CG, Carnahan RH, Crowe Jr. JE (2023). Potently neutralizing human mAbs against the zoonotic pararubulavirus Sosuga virus. JCI Insight. DOI: 10.1172/jci.insight.166811

Bennett, Monique & Dong, Jinhui & Bombardi, Robin & Soto, Cinque & Parrington, Helen & Nargi, Rachel & Schoeder, Clara & Nagel, Marcus & Schey, Kevin & Meiler, Jens & Skaar, Eric & Crowe, James. (2019). Human V H 1-69 Gene-Encoded Human Monoclonal Antibodies against Staphylococcus aureus IsdB Use at Least Three Distinct Modes of Binding To Inhibit Bacterial Growth and Pathogenesis. mBio. 10. 10.1128/mBio.02473-19

Diller, Julia & Parrington, Helen & Patton, John & Ogden, Kristen. (2019). Rotavirus species B encodes a functional fusion-associated small transmembrane (FAST) protein. Journal of Virology. 93. 10.1128/JVI.00813-19

You can view all of Dr Parrington's publications here.